Jascayd
Imported from official source
Jascayd Active substance Nerandomilast Holder Boehringer Ingelheim International GmbH Status Running Indication Treatment of adult patients with progressive pulmonary fibrosis Public documents Approbation Information for the patient Informed consent Last update 08/10/2026 valerie.coqu Thu, 10/08/2026 - 09:22
This version
- Version
- 1 of 1
- Recorded
- October 08, 2026 07:34
- Change
- Initial
- Content hash
2da280be21e17b01ad0e5755b7e0e3e2- All versions
- Revision history